-
p-Cresyl Sulfate: From Toxin to Assay Design
2026-08-20
Explore how p-Cresyl sulfate and p-tolyl hydrogen sulfate can support mechanistically resolved studies of endothelial dysfunction, valvular calcification, and uremic cardiovascular injury. This guide emphasizes phenotype selection, albumin-aware exposure design, and evidence-based assay interpretation.
-
Kupffer Cell Plasticity in Liver Metastasis
2026-08-20
This study shows that liver metastasis-associated macrophages are sustained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing and single-cell analyses suggest that effective myeloid remodeling may require simultaneous control of monocyte recruitment and macrophage expansion.
-
AICAR Workflows for AMPK Metabolic Research
2026-08-19
AICAR provides a practical, cell-permeable way to test whether AMPK signaling contributes to metabolic adaptation, mitochondrial quality control, and inflammatory responses. This workflow translates recent skeletal-muscle mitophagy findings into controlled dose screens, pathway-validation experiments, and troubleshooting strategies for metabolic disease research.
-
LL-37 Mimetics Reveal Selective Antibiofilm Activity
2026-08-19
The reference study compared the human host-defense peptide LL-37 with two truncated mimetics, KE-18 and KR-12, across Candida albicans, Staphylococcus aureus, and Escherichia coli. Its central finding is that antibacterial potency, biofilm prevention, and activity against established biofilms are separable phenotypes, highlighting the value of combining MIC, biomass, metabolic, and ligand-binding assays.
-
PTEN mRNA for PI3K/Akt Resistance
2026-08-18
A thought-leadership guide to using Cap 1, pseudouridine-modified PTEN mRNA as a mechanistically informed tool for studying PI3K/Akt-driven resistance, with practical guidance for delivery, controls, and translational decision-making.
-
Beyond Viability: Measuring Cancer Drug Responses
2026-08-18
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability to clarify whether an anticancer treatment primarily suppresses proliferation, induces cell death, or produces both effects. This framework has practical consequences for assay selection, timing, response interpretation, and studies of checkpoint abrogation or drug sensitization.
-
Cefoperazone Research Workflows and Assay Tips
2026-08-17
Cefoperazone sodium salt supports reproducible antimicrobial, β-lactamase-resistance, and biliary tract infection research workflows. This guide translates comparative susceptibility data into practical assay design, stock handling, controls, and troubleshooting strategies.
-
4-Hydroxytamoxifen Protocol & QC Guide
2026-08-17
4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled in vitro and in vivo workflows, including breast cancer research, prostate cancer research, and cardiac studies. It should not be selected for protocols that require aqueous or ethanol solubility, and the supplied dossier does not establish a universal dose, exposure time, or assay-specific outcome.
-
Ruthenium Red for Mechanostress Calcium Studies
2026-08-16
Ruthenium Red provides a practical perturbation tool for testing whether Ca2+ transport contributes to compression-induced autophagy. This guide connects cytoskeletal mechanotransduction with calcium signaling research while emphasizing dosing, controls, readouts, and troubleshooting.
-
Chloroquine Pharmacogenomics: Evidence and Implications
2026-08-15
The 2023 review by Biswas and Sukasem synthesizes evidence that CYP2C8, CYP3A5, CYP2D6, and related metabolic variation may alter chloroquine and hydroxychloroquine exposure, efficacy, and toxicity. Its main contribution is a risk-phenotype framework that connects ultra-rapid and poor metabolizer states with potential therapeutic failure or adverse effects while highlighting the limits of current evidence for clinical implementation.
-
Carbohydrate-Decorated Nanoparticles Target Macrophages
2026-08-14
Chen and colleagues developed biodegradable nanoparticles whose surface carbohydrates influenced macrophage uptake and reporter-gene expression. Mannose and dextran decoration produced particularly strong targeting-related effects, while the study also showed that the platform could efficiently encapsulate both mRNA and plasmid DNA with low observed cytotoxicity.
-
Caffeine Workflows for Cancer and Metabolic Research
2026-08-14
Caffeine provides a practical, water-compatible perturbation tool for cancer cell line inhibition, energy metabolism modulation, and obesity-related studies. This workflow guide pairs product-specific handling advice with a careful comparison to emerging ALDH2 activator research, helping researchers separate validated use cases from exploratory hypotheses.
-
Pomalidomide (CC-4047) in Myeloma Research
2026-08-13
Pomalidomide, also called CC-4047, is an immunomodulatory research compound used to study multiple myeloma and related hematological malignancies. Reported benchmarks include inhibition of LPS-induced TNF-α release at 13 nM, induction of fetal hemoglobin at 1 μM in human erythroid progenitor cells, and tumor-growth reduction in murine CNS lymphoma models.
-
Endothelial SGK1 and Salt-Induced Vascular Stiffening
2026-08-13
The reference study identifies endothelial SGK1 as a mechanistic link between mineralocorticoid–salt signaling, actin remodeling, and vascular stiffening. By combining endothelial-specific genetics with pharmacological inhibition in mouse and human endothelial models, it provides a framework for studying SGK1 in salt-sensitive vascular dysfunction and hypertension research.
-
Pam3CSK4 for Reliable TLR1/2 Assays
2026-08-12
Learn how Pam3CSK4 (SKU A9920) can be integrated into viability, proliferation, cytotoxicity, and inflammatory assays without confusing receptor-driven biology with assay artifacts. This scenario-based guide covers experimental controls, handling, interpretation, and practical vendor-selection criteria.